Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate CancerCameron Herberts, Alexander W. Wyatt, Scott North et al.|European Urology|2020Cited by 90
<i>BRCA2</i> , <i>ATM</i> , and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical AggressionEvan W. Warner, Alexander W. Wyatt, Cameron Herberts et al.|Clinical Cancer Research|2021Cited by 87
DNA repair defects in prostate cancer: impact for screening, prognostication and treatmentEvan W. Warner, Alexander W. Wyatt, Steven Yip et al.|British Journal of Urology|2018Cited by 40
Outcomes in patients (Pts) with advanced prostate cancer and inactivating germline mutations in BRCA2 or ATM.Steven Yip, Kim N., Daniel Khalaf et al.|Journal of Clinical Oncology|2018Cited by 3
Predictors of germline DNA damage repair gene mutations (gDDRm) in patients (pts) with metastatic castration-resistant prostate cancer (CRPC).Steven Yip, Kim N., Katherine Sunderland et al.|Journal of Clinical Oncology|2019Cited by 1